Comparison of Oncotype DX™ Recurrence Score by Histologic Subtype of Breast Carcinoma

被引：0
|
作者：
Bomeisl, P. E.
Thompson, C. L.
Harris, L. N.
Gilmore, H. L.
机构：
[1] Univ Hosp Case Med Ctr, Cleveland, OH USA
[2] Seidman Canc Ctr, Cleveland, OH USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
118
引用
收藏
页码：30A / 31A
页数：2
相关论文
共 50 条
  • [41] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Lindsay J. Collin
    Ming Yan
    Renjian Jiang
    Kevin C. Ward
    Brittany Crawford
    Mylin A. Torres
    Keerthi Gogineni
    Preeti D. Subhedar
    Samantha Puvanesarajah
    Mia M. Gaudet
    Lauren E. McCullough
    npj Breast Cancer, 5
  • [42] Invasive Lobular Carcinoma and Oncotype Dx®: Impact of Pathology and Recurrence Score on Treatment Plan
    Ross, D. S.
    Galman, L. C.
    Catalano, J.
    Tan, L. K.
    MODERN PATHOLOGY, 2012, 25 : 64A - 64A
  • [43] Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Shibata, Yukako
    Harada, Fumi
    Takeuchi, Hideki
    Yamada, Akimitsu
    Narui, Kazutaka
    Misumi, Toshihiro
    Ishikawa, Takashi
    Endo, Itaru
    IN VIVO, 2021, 35 (04): : 2439 - 2444
  • [44] Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
    Richard Buus
    Zsolt Szijgyarto
    Eugene F. Schuster
    Hui Xiao
    Ben P. Haynes
    Ivana Sestak
    Jack Cuzick
    Laia Paré
    Elia Seguí
    Nuria Chic
    Aleix Prat
    Mitch Dowsett
    Maggie Chon U. Cheang
    npj Breast Cancer, 7
  • [45] The Warwick Experience of the Oncotype DX® Breast Recurrence Score® Assay as a Predictor of Chemotherapy Administration
    Khan, Mashuk Alam
    Henderson, Laura
    Clarke, Dayalan
    Harries, Simon
    Jones, Lucie
    BREAST CARE, 2018, 13 (05) : 369 - 372
  • [46] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Collin, Lindsay J.
    Yan, Ming
    Jiang, Renjian
    Ward, Kevin C.
    Crawford, Brittany
    Torres, Mylin A.
    Gogineni, Keerthi
    Subhedar, Preeti D.
    Puvanesarajah, Samantha
    Gaudet, Mia M.
    McCullough, Lauren E.
    NPJ BREAST CANCER, 2019, 5 (1)
  • [47] Proposed criteria for luminal A breast cancer accurately predict Oncotype dx™ recurrence score
    Heinemann, F. S.
    BREAST, 2015, 24 : S116 - S116
  • [48] Invasive Lobular Carcinoma and Oncotype Dx®: Impact of Pathology and Recurrence Score on Treatment Plan
    Ross, D. S.
    Galman, L. C.
    Catalano, J.
    Tan, L. K.
    LABORATORY INVESTIGATION, 2012, 92 : 64A - 64A
  • [49] Bcl-2 Expression Correlates with Oncotype DX Recurrence Score in Mammary Carcinoma
    Xiang, Yan
    Li, Li
    Hou, J. Steve
    Garcia, Fernando
    Mohammed, Kareem
    Zarella, Mark
    LABORATORY INVESTIGATION, 2019, 99
  • [50] Correlation of Oncotype Dx Recurrence Score with Histologic Parameters, Biomarker Expression and KI-67 Index
    Henderson, S.
    Xie, X-J
    Peng, Y.
    Haley, B.
    Euhus, D.
    Leitch, M.
    Rao, R.
    Sarode, V.
    CANCER RESEARCH, 2010, 70
12345